plateau in Costa Rica: A review of causes and remedies. Environmental Conservation, 20(4): 317-323. Islam, M.M., Islam, M.A., & Chakroborthy, N. (2004). Fertility transition in Bangladesh: Understanding the role of proximate determinants. Journal of Biosocial Science , 36(3): 351-369. Ishida, K., Stupp, P., & Sotomayor, J.O. (2009). Stalled decline in fertility in Ecuador. International Perspectives on Sexual and Reproductive Health, 35(4): 203-206. Knodel, J., Chayovan, N., & Frisen, C. (1988). Has Thailand’s fertility decline stalled? Asia-Pacific Population
occupational noise. United States Army: Hearing Conservation Program. Washington DC: Dept of the Army Fact Sheet 51-002-0903, 2003. AS/NZS 1269:2005 Australia-New Zealand: Occupational Noise Management/Informative Appendix on Ototoxic Agents requiring hearing tests for those exposed to ototoxic agents.
global burden of occupational noise-induced hearing loss. Am J Ind Med 2005;48(6):446-58. Palmer KT, Griffin MJ, Syddall HE, Davis A, Pannett B, Coggon D. Occupational exposure to noise and the attributable burden of hearing difficulties in Great Britain. Occup Environ Med 2002;59(9):634-9. Meyer JD, Chen Y, McDonald JC, Cherry NM. Surveillance for work-related hearing loss in the UK: OSSA and OPRA 1997-2000. Occup Med (Lond) 2002;52(2):75-9. McBride DI. Noise-induced hearing loss and hearing conservation in mining. Occup Med (Lond) 2004;54(5):290-6. The
. 2002; 301: 7-14. 15. Wolf SJ, Bachtiar M, Wang J, Sim TS, Chong SS and Lee CGL, An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics. The Pharmacogenomics Journal. 2011; 11: 315-325. 16. Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics. 2002; 12: 437-450. 17. Kim DH, Lee NY
measures in blood transfusion [ 17 ]. In 2012, the neighboring country of Nepal in South Asia, India has launched a hemovigilance program, which is known as Haemovigilance Programme of India and makes a significant portion of a pharmacovigilance program at a nationwide level. With a roadmap of five years with four phases of hemovigilance, i.e., the phase of launching, the phase of expanding and partnership, the phase of development and conservation, and the phase of optimizing, it is an all-inclusive, integrated, and well-structured method [ 18 ]. Scope of Hemovigilance